Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects
Clinical trial NCT05945810 · COMPLETED
Trial details
- NCT number
- NCT05945810
- Sponsor
- Hangzhou Highlightll Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-12
- Primary completion
- 2023-08-28
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.